Cite
Addendum to: “Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries” [Eur Urol 2009;55:957–68]
MLA
Buvat, Jacques, et al. “Addendum to: ‘Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries’ [Eur Urol 2009;55:957–68].” European Urology, vol. 56, no. 1, July 2009, pp. e14–15. EBSCOhost, https://doi.org/10.1016/j.eururo.2009.04.035.
APA
Buvat, J., Tesfaye, F., Rothman, M., Rivas, D. A., & Giuliano, F. (2009). Addendum to: “Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries” [Eur Urol 2009;55:957–68]. European Urology, 56(1), e14–e15. https://doi.org/10.1016/j.eururo.2009.04.035
Chicago
Buvat, Jacques, Fisseha Tesfaye, Margaret Rothman, David A. Rivas, and François Giuliano. 2009. “Addendum to: ‘Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries’ [Eur Urol 2009;55:957–68].” European Urology 56 (1): e14–15. doi:10.1016/j.eururo.2009.04.035.